Introduction
DMO, Retinal hypoxia, vision loss, diabetes [
DIABETIC MACULAR OEDEMA
Diabetic macular oedema (DMO) is the most frequent cause of vision loss in patients with diabetes [Retinal hypoxia elevates levels of VEGF through activation of hypoxia-inducible factor [The present study treated DMO with aflibercept following a treat-and-extend (T&E) protocol from enrolment. The DAVE Trial randomised 40 eyes with DMO to either ranibizumab 